BLFS
Price
$20.83
Change
-$0.21 (-1.00%)
Updated
Jul 18 closing price
Capitalization
810.87M
17 days until earnings call
TCMD
Price
$9.52
Change
-$0.49 (-4.90%)
Updated
Jul 18 closing price
Capitalization
369.35M
21 days until earnings call
Interact to see
Advertisement

BLFS vs TCMD

Header iconBLFS vs TCMD Comparison
Open Charts BLFS vs TCMDBanner chart's image
BioLife Solutions
Price$20.83
Change-$0.21 (-1.00%)
Volume$408.13K
Capitalization810.87M
Tactile Systems Technology
Price$9.52
Change-$0.49 (-4.90%)
Volume$146.97K
Capitalization369.35M
BLFS vs TCMD Comparison Chart in %
Loading...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLFS vs. TCMD commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLFS is a Hold and TCMD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (BLFS: $20.83 vs. TCMD: $9.52)
Brand notoriety: BLFS and TCMD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLFS: 75% vs. TCMD: 54%
Market capitalization -- BLFS: $810.87M vs. TCMD: $369.35M
BLFS [@Medical Specialties] is valued at $810.87M. TCMD’s [@Medical Specialties] market capitalization is $369.35M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLFS’s FA Score shows that 1 FA rating(s) are green whileTCMD’s FA Score has 1 green FA rating(s).

  • BLFS’s FA Score: 1 green, 4 red.
  • TCMD’s FA Score: 1 green, 4 red.
According to our system of comparison, TCMD is a better buy in the long-term than BLFS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLFS’s TA Score shows that 2 TA indicator(s) are bullish while TCMD’s TA Score has 3 bullish TA indicator(s).

  • BLFS’s TA Score: 2 bullish, 7 bearish.
  • TCMD’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, TCMD is a better buy in the short-term than BLFS.

Price Growth

BLFS (@Medical Specialties) experienced а -5.10% price change this week, while TCMD (@Medical Specialties) price change was -4.42% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.11%. For the same industry, the average monthly price growth was +2.74%, and the average quarterly price growth was -1.25%.

Reported Earning Dates

BLFS is expected to report earnings on Aug 07, 2025.

TCMD is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (-0.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLFS($811M) has a higher market cap than TCMD($369M). BLFS has higher P/E ratio than TCMD: BLFS (238.10) vs TCMD (12.72). BLFS YTD gains are higher at: -19.761 vs. TCMD (-44.425). TCMD has higher annual earnings (EBITDA): 24.5M vs. BLFS (-45.24M). TCMD has more cash in the bank: 75.2M vs. BLFS (51.7M). BLFS has less debt than TCMD: BLFS (42.7M) vs TCMD (50.4M). TCMD has higher revenues than BLFS: TCMD (274M) vs BLFS (143M).
BLFSTCMDBLFS / TCMD
Capitalization811M369M220%
EBITDA-45.24M24.5M-185%
Gain YTD-19.761-44.42544%
P/E Ratio238.1012.721,871%
Revenue143M274M52%
Total Cash51.7M75.2M69%
Total Debt42.7M50.4M85%
FUNDAMENTALS RATINGS
BLFS vs TCMD: Fundamental Ratings
BLFS
TCMD
OUTLOOK RATING
1..100
2126
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
90100
SMR RATING
1..100
9076
PRICE GROWTH RATING
1..100
7989
P/E GROWTH RATING
1..100
1517
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TCMD's Valuation (62) in the Medical Specialties industry is somewhat better than the same rating for BLFS (95). This means that TCMD’s stock grew somewhat faster than BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (90) in the Medical Specialties industry is in the same range as TCMD (100). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

TCMD's SMR Rating (76) in the Medical Specialties industry is in the same range as BLFS (90). This means that TCMD’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Price Growth Rating (79) in the Medical Specialties industry is in the same range as TCMD (89). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

BLFS's P/E Growth Rating (15) in the Medical Specialties industry is in the same range as TCMD (17). This means that BLFS’s stock grew similarly to TCMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BLFSTCMD
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
75%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
77%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
78%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend about 1 month ago
85%
Bearish Trend 25 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
71%
Aroon
ODDS (%)
Bearish Trend 5 days ago
85%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EGOIX19.700.08
+0.41%
Allspring Large Cap Core Inst
FEREX11.730.03
+0.26%
First Eagle Global Real Assets I
YACKX24.34N/A
N/A
AMG Yacktman I
DWOCX15.33-0.02
-0.13%
BNY Mellon Research Growth C
HSEIX12.19-0.09
-0.73%
Hartford Small Cap Value I

TCMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCMD has been loosely correlated with OFIX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TCMD jumps, then OFIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCMD
1D Price
Change %
TCMD100%
-4.90%
OFIX - TCMD
54%
Loosely correlated
-2.03%
AORT - TCMD
43%
Loosely correlated
-1.17%
BVS - TCMD
42%
Loosely correlated
-3.54%
BLFS - TCMD
39%
Loosely correlated
-1.00%
CSTL - TCMD
39%
Loosely correlated
-4.89%
More